These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 25889684

  • 1. Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms.
    Xu RX, Liu J, Li XL, Li S, Zhang Y, Jia YJ, Sun J, Li JJ.
    J Transl Med; 2015 Mar 14; 13():87. PubMed ID: 25889684
    [Abstract] [Full Text] [Related]

  • 2. Proprotein convertase subtilisin/kexin type 9 expression is transiently up-regulated in the acute period of myocardial infarction in rat.
    Zhang Y, Liu J, Li S, Xu RX, Sun J, Tang Y, Li JJ.
    BMC Cardiovasc Disord; 2014 Dec 17; 14():192. PubMed ID: 25519174
    [Abstract] [Full Text] [Related]

  • 3. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
    Yang X, Zhang J, Chen L, Wu Q, Yu C.
    Exp Cell Res; 2018 May 15; 366(2):152-160. PubMed ID: 29548750
    [Abstract] [Full Text] [Related]

  • 4. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.
    Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH.
    Mol Nutr Food Res; 2014 Nov 15; 58(11):2133-45. PubMed ID: 25164566
    [Abstract] [Full Text] [Related]

  • 5. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.
    Dong B, Wu M, Li H, Kraemer FB, Adeli K, Seidah NG, Park SW, Liu J.
    J Lipid Res; 2010 Jun 15; 51(6):1486-95. PubMed ID: 20048381
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y, Chen Y, Hu W, Li X, Yang X, Zhou X, Yin Z, Kong D, Yao Z, Hajjar DP, Liu L, Liu Q, Han J.
    J Biol Chem; 2012 Jul 06; 287(28):23667-77. PubMed ID: 22593575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M, Terao Y, Ayaori M, Uto-Kondo H, Iizuka M, Yogo M, Hagisawa K, Takiguchi S, Yakushiji E, Nakaya K, Ogura M, Komatsu T, Ikewaki K.
    Arterioscler Thromb Vasc Biol; 2014 Jun 06; 34(6):1171-8. PubMed ID: 24675665
    [Abstract] [Full Text] [Related]

  • 9. Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats.
    Jia L, Song N, Yang G, Ma Y, Li X, Lu R, Cao H, Zhang N, Zhu M, Wang J, Leng X, Cao Y, Du Y, Xu Y.
    Mol Med Rep; 2016 Jun 06; 13(6):4627-35. PubMed ID: 27082100
    [Abstract] [Full Text] [Related]

  • 10. Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.
    Cui CJ, Li S, Zhu CG, Sun J, Du Y, Zhang Y, Wu NQ, Guo YL, Xu RX, Gao Y, Li JJ.
    J Cell Mol Med; 2016 Dec 06; 20(12):2374-2383. PubMed ID: 27633999
    [Abstract] [Full Text] [Related]

  • 11. Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
    Miyazawa H, Tabeta K, Miyauchi S, Aoki-Nonaka Y, Domon H, Honda T, Nakajima T, Yamazaki K.
    Lipids Health Dis; 2012 Sep 19; 11():121. PubMed ID: 22992388
    [Abstract] [Full Text] [Related]

  • 12. Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice.
    Shende VR, Wu M, Singh AB, Dong B, Kan CF, Liu J.
    J Lipid Res; 2015 Apr 19; 56(4):801-9. PubMed ID: 25652089
    [Abstract] [Full Text] [Related]

  • 13. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D, Pöss J, Böhm M, Laufs U.
    J Am Coll Cardiol; 2013 Oct 15; 62(16):1401-8. PubMed ID: 23973703
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the proprotein convertase subtilisin/kexin type 9 in intestinal epithelial cells.
    Leblond F, Seidah NG, Précourt LP, Delvin E, Dominguez M, Levy E.
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr 15; 296(4):G805-15. PubMed ID: 19179626
    [Abstract] [Full Text] [Related]

  • 15. [Lipid-lowering drugs and PCSK9].
    Millán Núñez-Cortés J, Mostaza Prieto JM.
    Clin Investig Arterioscler; 2016 May 15; 28 Suppl 2():9-13. PubMed ID: 27888906
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
    Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP.
    Transl Res; 2012 Aug 15; 160(2):125-30. PubMed ID: 22683370
    [Abstract] [Full Text] [Related]

  • 17. Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters.
    Wu M, Dong B, Cao A, Li H, Liu J.
    Atherosclerosis; 2012 Oct 15; 224(2):401-10. PubMed ID: 22954675
    [Abstract] [Full Text] [Related]

  • 18. Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells.
    Choi HK, Hwang JT, Nam TG, Kim SH, Min DK, Park SW, Chung MY.
    Food Funct; 2017 Dec 13; 8(12):4582-4591. PubMed ID: 29130084
    [Abstract] [Full Text] [Related]

  • 19. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
    Yang JH, Bang MA, Jang CH, Jo GH, Jung SK, Ki SH.
    J Nutr Biochem; 2015 Nov 13; 26(11):1393-400. PubMed ID: 26320675
    [Abstract] [Full Text] [Related]

  • 20. Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats.
    Jia YJ, Xu RX, Sun J, Tang Y, Li JJ.
    J Transl Med; 2014 Apr 23; 12():103. PubMed ID: 24755036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.